日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome

临床前策略和新兴技术推动α-半乳糖综合征的研究进展

Erickson, Loren D; Wilson, Jeffrey M; Cramton, Kayla; Rival, Claudia M

Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal syndrome

在α-半乳糖综合征小鼠模型中,采用包裹寡糖半乳糖-α-1,3-半乳糖的可生物降解纳米颗粒进行免疫治疗,可增强对α-半乳糖致敏的免疫耐受性。

Saunders, Michael N; Rival, Claudia M; Mandal, Mahua; Cramton, Kayla; Rad, Laila M; Janczak, Katarzyna W; Williams, Laura A; Angadi, Amogh R; O'Konek, Jessica J; Shea, Lonnie D; Erickson, Loren D

Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.

异柠檬酸盐通过抑制红细胞铁限制反应来改善贫血

Richardson Chanté L, Delehanty Lorrie L, Bullock Grant C, Rival Claudia M, Tung Kenneth S, Kimpel Donald L, Gardenghi Sara, Rivella Stefano, Goldfarb Adam N